Kyle Staller

The implementation of colorectal cancer screening interventions in low-and middle-income countries: a scoping review

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells

Coinfection With HIV-1 and HCV—A One-Two Punch

A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease

Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1

Evolution of Innate and Adaptive Effector Cell Functions during Acute HIV‐1 Infection

Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial

The end of AIDS: HIV infection as a chronic disease

Influence of diet on the gut microbiome and implications for human health

ACG Clinical Guideline: Management of Benign Anorectal Disorders

Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells

Irritable Bowel Syndrome

Control of Human Viral Infections by Natural Killer Cells

Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection

Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals

Innate or Adaptive Immunity? The Example of Natural Killer Cells

KIR and disease: a model system or system of models?

Rectosigmoid Localization of Radiopaque Markers Does Not Correlate with Prolonged Balloon Expulsion in Chronic Constipation: Results from a Multicenter Cohort

Cancer risk in microscopic colitis: a retrospective cohort study

Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection